Back to Search
Start Over
The peri-operative management of anti-platelet therapy in elective, non-cardiac surgery.
- Source :
-
International journal of cardiology [Int J Cardiol] 2013 Jul 31; Vol. 167 (2), pp. 374-7. Date of Electronic Publication: 2012 Jan 23. - Publication Year :
- 2013
-
Abstract
- Background: Cardiovascular complications are important causes of morbidity and mortality in patients undergoing elective non-cardiac surgery, with adverse cardiac outcomes estimated to occur in approximately 4% of all patients. Anti-platelet therapy withdrawal may precede up to 10% of acute cardiovascular syndromes, with withdrawal in the peri-operative setting incompletely appraised.<br />Objectives: The aims of our study were to determine the proportion of patients undergoing elective non-cardiac surgery currently prescribed anti-platelet therapy, and identify current practice in peri-operative management. In addition, the relationship between management of anti-platelet therapy and peri-operative cardiac risk was assessed.<br />Methods: We evaluated consecutive patients attending elective non-cardiac surgery at a major tertiary referral centre. Clinical and biochemical data were collected and analysed on patients currently prescribed anti-platelet therapy. Peri-operative management of anti-platelet therapy was compared with estimated peri-operative cardiac risk.<br />Results: Included were 2950 consecutive patients, with 516 (17%) prescribed anti-platelet therapy, primarily for ischaemic heart disease. Two hundred and eighty nine (56%) patients had all anti-platelet therapy ceased in the peri-operative period, including 49% of patients with ischaemic heart disease and 46% of patients with previous coronary stenting. Peri-operative cardiac risk score did not influence anti-platelet therapy management.<br />Conclusions: Approximately 17% of patients undergoing elective non-cardiac surgery are prescribed anti-platelet therapy, the predominant indication being for ischaemic heart disease. Almost half of all patients with previous coronary stenting had no anti-platelet therapy during the peri-operative period. The decision to cease anti-platelet therapy, which occurred commonly, did not appear to be guided by peri-operative cardiac risk stratification.<br /> (Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.)
- Subjects :
- Aged
Aged, 80 and over
Disease Management
Elective Surgical Procedures adverse effects
Female
Humans
Male
Middle Aged
Myocardial Ischemia drug therapy
Myocardial Ischemia epidemiology
Myocardial Ischemia prevention & control
Prospective Studies
Risk Factors
Elective Surgical Procedures methods
Perioperative Care methods
Platelet Aggregation Inhibitors administration & dosage
Subjects
Details
- Language :
- English
- ISSN :
- 1874-1754
- Volume :
- 167
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- International journal of cardiology
- Publication Type :
- Academic Journal
- Accession number :
- 22273438
- Full Text :
- https://doi.org/10.1016/j.ijcard.2011.12.096